By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Drug research software maker Simulations Plus will use Symyx's Metabolite database to develop and improve a predictive modeling system for in silico metabolic properties, Symyx said today.

Simulations Plus plans to develop a new module used for predictive modeling of ADMET (absorption, distribution, metabolism, excretion, and toxicity) applications.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: GWAS links gene to noise-induced hearing loss in mice, population genetics of malaria parasites, and more.

Nautilus' Alexandra Ossola examines how Tay-Sachs disease jump-started the genetic disease testing field.

FASEB says guidelines proposed by the NIH to bolster research reproducibility are premature and don't take the full range of scientific studies into consideration.

Liquid biopsies and DNA tests may be able to tell physicians whether a cancer patient is relapsing, the New York Times reports.

May
28
Sponsored by
PerkinElmer

This online seminar will demonstrate how RNA-seq analysis in a model organism can provide insights into human disease.